US5942410A - Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol - Google Patents
Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol Download PDFInfo
- Publication number
- US5942410A US5942410A US08/888,434 US88843497A US5942410A US 5942410 A US5942410 A US 5942410A US 88843497 A US88843497 A US 88843497A US 5942410 A US5942410 A US 5942410A
- Authority
- US
- United States
- Prior art keywords
- composition
- staining
- metabisulfite
- present
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 86
- 238000000034 method Methods 0.000 title claims abstract description 75
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 title claims abstract description 69
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 58
- 238000010186 staining Methods 0.000 title claims abstract description 55
- 108091092356 cellular DNA Proteins 0.000 title claims abstract description 33
- -1 thiazine derivative metabisulfite Chemical class 0.000 title 1
- 125000002091 cationic group Chemical group 0.000 claims abstract description 29
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 claims abstract description 25
- 230000001476 alcoholic effect Effects 0.000 claims abstract description 8
- 239000000243 solution Substances 0.000 claims description 36
- 108020004414 DNA Proteins 0.000 claims description 28
- 239000012192 staining solution Substances 0.000 claims description 28
- 229910052739 hydrogen Inorganic materials 0.000 claims description 17
- 239000001257 hydrogen Substances 0.000 claims description 17
- 230000003287 optical effect Effects 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical group CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 9
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 235000010263 potassium metabisulphite Nutrition 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical group [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical group [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- 101150108015 STR6 gene Proteins 0.000 claims 1
- 108010076830 Thionins Proteins 0.000 abstract description 47
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 abstract 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 62
- JOIRQYHDJINFGA-UHFFFAOYSA-N (7-aminophenothiazin-3-ylidene)azanium;acetate Chemical compound CC([O-])=O.C1=CC(=[NH2+])C=C2SC3=CC(N)=CC=C3N=C21 JOIRQYHDJINFGA-UHFFFAOYSA-N 0.000 description 48
- 210000004027 cell Anatomy 0.000 description 38
- 239000003153 chemical reaction reagent Substances 0.000 description 30
- 210000004940 nucleus Anatomy 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000005259 measurement Methods 0.000 description 10
- 239000012128 staining reagent Substances 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 9
- 238000009649 Feulgen staining Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000004163 cytometry Methods 0.000 description 6
- 229940001584 sodium metabisulfite Drugs 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 5
- 108010077544 Chromatin Proteins 0.000 description 4
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 4
- 210000003483 chromatin Anatomy 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000834 fixative Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003929 acidic solution Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000001744 histochemical effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 238000007447 staining method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000005859 cell recognition Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 2
- 239000003517 fume Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 230000007064 DNA hydrolysis Effects 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000003779 cell fixation method Methods 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001516 effect on protein Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- VLDWOOKCNKECMS-UHFFFAOYSA-N ethanol methanol 2-methylpropan-2-ol Chemical compound CO.CCO.CC(C)(C)O VLDWOOKCNKECMS-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 125000001484 phenothiazinyl group Chemical class C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 230000001855 preneoplastic effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B21/00—Thiazine dyes
-
- G01N15/1433—
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Definitions
- the present invention generally relates to a composition and method for staining cellular DNA, and more particularly, to a composition that includes a cationic stain and methods for its use.
- Image cytometry has been increasingly used in cytopathology and histopathology to detect aneuploid cell populations within preneoplastic or neoplastic lesions.
- DNA image cytometry has gained wide acceptance in pathology and cytopathology as a means to obtain diagnostic and prognostic information for human cancer. Such diagnoses require the accurate determination of cellular DNA content. Accordingly, various methods for quantitatively staining nuclear DNA have been developed. The reproducibility and reliability of several quantitative DNA stains has been recently reported. "A Comparative Study of Quantitative Stains for DNA in Image Cytometry," Mickel, U. V. and Becker, Jr., R. L., Analytical and Quantitative Cytology and Histology 1991, 13:253-260.
- Feulgen staining techniques Feulgen, R. and Voit K., Z. Physiol. Chem. 1924, 136:57-61. Feulgen discovered that hydrolysis of fixed tissues (i.e., DNA hydrolysis) exposed the deoxypentose present in cell nuclei in an aldehyde form. Subsequently, Feulgen found that the mild acid hydrolysis of cellular DNA followed by the addition of a Schiff reagent provided a reddish-purple color to DNA-containing structures.
- the Feulgen technique continues to be practiced as a method for quantitating cellular DNA and generally involves the steps of oxidizing nucleic acids to provide aldehydes, and reacting these aldehydes with a Schiff reagent to form a purple-red color indicative of the presence of DNA. Because the reaction is stoichiometric, the intensity of the color is directly related to the amount of DNA in the sample, provided that excess reagents are washed out.
- a thionin-sulfite reagent was found to exclusively stain nuclei of hydrolyzed sections of mouse kidney and liver cell nuclei. Van Duijn, P., J. Histochem. Cytochem. 1956, 4:55-63.
- the aldehyde reagent contained thionin and sulfur dioxide in a medium of t-butanol and water.
- This thionin reagent was prepared by acidifying a solution of thionin in aqueous t-butanol (water:t-butanol, 1:1) with aqueous hydrochloric acid followed by the addition of sodium metabisulfite.
- Van Duijn concluded from the histochemical data that the thionin-sulfite/t-butanol reagent contains one or more components that react with aldehydes, although the exact chemical nature of the reaction between thionin and sulfur dioxide and the nucleic acids was unclear.
- the use of Feulgen staining methods has continued to present, and various compounds have been used as Feulgen stains.
- Thionin generally regarded as a nuclear stain, is one of the more commonly used stains in the Feulgen procedure.
- the composition of the reagent has remained unchanged (i.e., a solution of thionin and sodium metabisulfite in aqueous t-butanol adjusted to about pH 1.5 with aqueous hydrochloric acid).
- t-butanol is an irritating substance and presents a work hazard.
- t-butanol In contrast to other simple alcohols, t-butanol is extremely expensive (e.g., $45 per liter compared to methanol or ethanol at about $2 per liter). Perhaps most importantly, the useful shelf life of thionin/t-butanol staining solutions is about two days. Such a short shelf life precludes the storage and therefore commercial utility of such a reagent, and requires one who wishes to use the thionin reagent in a Feulgen staining method to prepare the reagent immediately prior to use.
- a thionin-based reagent that offers the advantages of cellular DNA quantitation afforded by the traditional thionin/t-butanol staining reagent without the accompanying disadvantages associated with t-butanol, a key component of the reagent. More specifically, there exists a need for a thionin staining reagent that has a long and stable shelf life. The present invention seeks to fulfill these needs and provides further related advantages.
- the present invention provides a composition that is useful for staining cellular DNA.
- the composition is an aqueous alcoholic solution that includes a cationic stain having a formula: ##STR1## where R 1 and R 2 are independently selected from hydrogen and methyl, and X is a counterion; a metabisulfite; and an alcohol selected from either methanol ethanol, and mixtures of methanol and ethanol.
- the cationic stain is thionin acetate (i.e., R 1 and R 2 are hydrogen and X is acetate).
- a method for staining cellular DNA is provided.
- the composition noted above is applied to a cell to provide a cell having a stained nucleus.
- the present invention also provides a method for quantitating cellular DNA that includes the steps of staining the cell with the composition noted above to provide a cell having a stained nucleus, and then measuring the optical density of the stain nucleus to determine the presence or amount of DNA present in the nucleus.
- the present invention provides a kit for staining cellular DNA that includes the composition noted above.
- the present invention generally relates to a composition and method for staining cellular DNA. More specifically, the present invention provides a composition that is useful as a reagent in a Feulgen staining method and useful in both staining and determining the presence or amount of cellular DNA.
- the composition of the present invention is an aqueous alcoholic solution that includes a cationic dye, a metabisulfite, and an alcohol preferably selected from methanol, ethanol, and mixtures of ethanol and methanol.
- the cationic stain useful in the composition of the present invention is a phenothiazine derivative, and more specifically, a 3,7-diamino-5-phenothiazine derivative.
- the cationic stain is represented by the following formula: ##STR2## where R 1 and R 2 are either hydrogen, methyl, or combinations of hydrogen and methyl, and X is a counterion. While the cationic stain useful in the composition of the present invention is represented by the formula above, it will be appreciated that the cationic stain may also be represented by other equivalent formulas including: ##STR3##
- Suitable cationic stains include Azure A (R 1 and R 2 are methyl) and Azure C (R 1 is methyl and R 2 is hydrogen).
- the cationic stain is thionin (R 1 and R 2 are hydrogen).
- Suitable counterions X include anions that do not adversely affect the performance of the cationic stain in the staining procedure and include acetate, chloride, and bromide.
- the counterion is acetate.
- the cationic stain is thionin acetate (R 1 and R 2 are hydrogen and X is acetate).
- the cationic stain is present in the composition at a concentration from about 1.0 ⁇ 10 -3 M to about 2.5 ⁇ 10 -2 M, and preferably from about 4.0 ⁇ 10 -3 M to about 8.0 ⁇ 10 -3 M.
- the composition of the present invention also preferably includes a metabisulfite. While embodiments of the present invention that include bisulfite are useful as staining solutions, it has been found that metabisulfite containing solutions provide the best staining results. Suitable metabisulfites do not adversely affect the staining performance of the composition of the present invention. Suitable metabisulfites include metal metabisulfites such as lithium, sodium, and potassium metabisulfites. Preferably, the composition includes either sodium or potassium metabisulfite.
- the metabisulfite is present in the composition at a concentration from about 1.0 ⁇ 10 -3 M to about 2.5 ⁇ 10 -2 M, and preferably from about 4.0 ⁇ 10 -3 M to about 8.0 ⁇ 10 -3 M.
- a molar metabisulfite:thionin ratio of 1:1 is preferred.
- the composition of the present invention includes a cationic stain and a metabisulfite in aqueous alcohol.
- the aqueous alcohol solution serves to solubilize the stain and metabisulfite as well as any active DNA staining components formed in the solution. Therefore, the alcohol is preferably miscible with water and, for ease of reagent preparation, a liquid at room temperature.
- Alcohols useful in the composition include C1 to C3 alcohols (i.e., methanol, ethanol, n-propanol and isopropanol), and mixtures of these alcohols.
- Preferred alcohols include methanol, ethanol, and mixtures of methanol and ethanol.
- the aqueous alcohol solution contains from about 20 to about 60 percent alcohol, and more preferably, about 40 percent alcohol.
- the composition of the present invention is preferably an aqueous acidic solution having a pH of from about 1.0 to about 2.0, and more preferably, from about 1.3 to about 1.5. While the pH of the composition can be adjusted with any one of a number of acids, the pH of the solution is preferably adjusted with aqueous hydrochloric acid.
- Example 1 The preparation of a representative composition of the present invention, a thionin/methanol staining solution, is described in Example 1.
- the reaction of the above-noted cationic stain with metabisulfite results in the formation of an active ingredient that binds to hydrolyzed DNA.
- the composition of the present invention is useful for staining cellular DNA.
- the present invention provides a method for staining cellular DNA.
- the composition described above is applied to cells to provide cells having stained nuclei.
- Basic procedures such as cell fixation, dehydration, clearing, staining, and mounting, as well as specific staining methods, including Feulgen techniques, nucleic acid staining, and the staining of cellular elements, are well known to those of skill in the art.
- the method of the present invention includes applying the composition described above to cells.
- the composition and method of the present invention are useful in staining virtually any cell having a nucleus including, for example, epithelial, muscle, nerve, and connective tissue cells.
- Any one of a number of cell preparations may be used in the method, for example, preparations of cells of interest include conventional smears, histological preparations, and monolayer preparations.
- cells are deposited on a microscope slide for staining. After deposit on the slide, the cells are fixed by immersing the slide in a fixative solution and then rinsed. Alternatively, fixed cells may also be deposited on the slide for staining.
- the cellular DNA is then hydrolyzed by immersing the slides in an acidic solution. Following another rinse, the cells are stained by immersing the slides in a staining solution. After additional rinses, the cells are then dehydrated by immersion in ethanol solutions, followed by clearing in xylene.
- the staining results may be visualized by any one of a number of techniques including manual and automated techniques including, for example, microscopic and image cytometric techniques.
- a detailed method for a representative staining procedure that includes the method of the present invention is described in Example 1. Although the staining procedure may be a manual procedure, the method of the present invention may also be incorporated into an automated staining procedure.
- the staining method of the present invention is a quantitative method for staining cellular DNA
- the combination of the steps of staining cells with the staining solution of the present invention and measuring the optical density of the resulting stained nuclei permits the determination of the presence or amount of DNA present in a cell's nucleus.
- the present invention provides a method for quantitating cellular DNA that includes the steps of staining the cell with the composition described above, and then measuring the optical density of the stained nuclei to determine either the presence or the amount of DNA present in the nucleus.
- the optical densities of stained nuclei may be measured by manual and automated techniques including, for example, optical scanners, microscopes, and other image cytometers.
- Suitable instruments for measuring the optical densities of stained cells are known in the art and include those described in "The Design and Development of an Optical Scanner for Cell Biology,” Jaggi, B. and Palcic, B., IEEE Proc. Eng. Med. Biol. 1985; 2:980-985; "Cell Recognition Algorithms for the Cell Analyzer,” Jaggi, B. and Palcic B., IEEE Proc. Eng. Med. Biol. 1987; 4:1454-1456; and "Design of a Solid State Microscope," Jaggi, B., Deen, M. J., and Palcic B., Opt. Engineer 1989; 28(6):7675-682, each expressly incorporated herein by reference.
- the methods of the present invention are useful in techniques in which stained cells are digitally imaged and the resulting digital intensity images manipulated by computer to perform a variety of cell feature measurements.
- Cellular features such as the size, shape, and DNA content of the nucleus, and other features that describe the spatial distribution of chromatin within the nucleus, can be calculated.
- Features that describe the chromatin distribution are collectively referred to as texture features, and texture features can be selected for their ability to differentiate between the various descriptive classes of chromatin patterns and to further provide quantitative information regarding the extent of changes in chromatin patterns associated with certain diseases including, for example, malignancy.
- the composition and methods of the present invention are useful in nuclear texture measurements, and consequently the diagnosis and prognosis of certain diseases.
- IOD integrated optical density
- the composition of the present invention provides cellular DNA staining comparable to the standard thionin/t-butanol staining solution, and (2) the ability of the composition of the present invention to effectively stain cellular DNA remains essentially constant over a period of about five weeks.
- the conventional thionin/t-butanol staining solution loses about 40 percent of its staining capacity in only four days.
- the enhanced stability of the composition of the present invention compared to the conventional staining solution offers significant practical and commercial advantages. For example, while the conventional staining solution must be freshly prepared immediately prior to staining by the practitioner or clinician, the composition of the present invention, by virtue of their stability and long shelf life, may be prepared, stored, and used repeatedly over a relatively long period of time.
- the extent to which the associated protein is denatured, and the extent to which DNA is made available for measurement, is highly dependent on the reagents and methods employed. For instance, in formalin fixation methods, the concentration of alcohol in the fixation reagent has been found to have a critical effect on protein denaturation and, consequently, the quantitative measurement of intracellular DNA. In general, the effect of a specific solvent or reagent on a quantitative DNA method is largely unpredictable and may typically be determined empirically through experimentation.
- the composition and method of the present invention have been found to be effective in quantitating intracellular DNA.
- the present composition is as effective in staining intracellular DNA as the standard t-butanol-based composition.
- the present composition provides a staining reagent that has a stable shelf life considerably greater than the standard staining composition.
- the present invention provides a kit for staining cellular DNA.
- the kit of the present invention includes the composition described above.
- composition components are contained in one or more vessels in the kit.
- the kit includes a staining reagent that incorporates all of the components of the composition of the present invention in a single solution (i.e., an aqueous alcoholic solution of a cationic dye and a metabisulfite adjusted to about pH 1.5).
- the kit includes a staining reagent in dry (i.e., powdered) form.
- the kit can contain solid cationic stain in one vessel and solid metabisulfite in a second vessel.
- the liquid components of the composition are added to the dry reagents which are then combined to provide the staining solution of the invention.
- the kit can include a combination of solid cationic stain and metabisulfite in a single vessel.
- the kit also includes a rinse reagent (i.e., an aqueous acidic solution of metabisulfite).
- a rinse reagent i.e., an aqueous acidic solution of metabisulfite
- the rinse reagent may be provided as a solid or in solution.
- the kit can optionally include unstained, cultured cells on microscope slides (control slides) to, for example, monitor quality control of the staining procedure.
- the kit can also include an instruction booklet that provides directions for the staining procedure and, for applicable embodiments, directions for preparing the staining solution from the kit's reagents.
- a representative procedure for staining cellular DNA with alcohol solutions of thionin is described.
- the reagents used in the DNA staining procedure including methanol and t-butanol solutions of thionin, and fixative and rinse solutions, were prepared as described below.
- the reagents prepared as described above were then used to stain cellular DNA by the following method.
- Preparations of cells of interest e.g., cells from uterine cervix samples
- cells of interest including conventional smears and monolayer preparations, may be used in the method.
- cells are generally deposited on a microscope slide for staining.
- This example compares the cellular DNA staining performance of thionin/methanol and thionin/t-butanol staining solutions over time.
- thionin solutions were prepared in either methanol or t-butanol, as described in Example 1 above, and cellular preparations were stained and the optical densities of the stained nuclei measured.
- cellular stainings with each thionin solution were performed at regular time intervals (see Table 1 below) with the same stock staining solution.
- the comparative experiment determined the useful shelf life of each of the specific thionin staining reagents studied.
Abstract
Description
______________________________________ Thionin Solution Day t-Butanol Methanol Ethanol ______________________________________ 0 114.7 ± 4.2 120.0 ± 2.0 120.9 ± 1.6 1 117.3 ± 3.5 -- -- 2 123.0 ± 5.7 -- -- 3 85.3 ± 3.1 -- -- 4 68.3 ± 4.7 -- -- 7 -- 119.7 ± 3.1 116.2 ± 5.6 14 -- 119.3 ± 2.1 118.9 ± 1.2 21 -- 117.7 ± 2.5 113.3 ± 3.3 28 -- 119.7 ± 2.1 106.5 ± 1.8 35 -- 112.0 ± 2.0 114.4 ± 6.0 ______________________________________
Claims (24)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/888,434 US5942410A (en) | 1997-07-07 | 1997-07-07 | Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol |
US08/907,532 US6026174A (en) | 1992-10-14 | 1997-08-08 | System and method for automatically detecting malignant cells and cells having malignancy-associated changes |
EP98931863A EP0996852A1 (en) | 1997-07-07 | 1998-07-07 | Composition and method for staining cellular dna |
AU82029/98A AU8202998A (en) | 1997-07-07 | 1998-07-07 | Composition and method for staining cellular dna |
JP2000502393A JP4212232B2 (en) | 1997-07-07 | 1998-07-07 | Compositions and methods for staining cellular DNA |
PCT/CA1998/000658 WO1999002960A1 (en) | 1997-07-07 | 1998-07-07 | Composition and method for staining cellular dna |
CA002295545A CA2295545C (en) | 1997-07-07 | 1998-07-07 | Composition and method for staining cellular dna |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/888,434 US5942410A (en) | 1997-07-07 | 1997-07-07 | Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/644,893 Continuation-In-Part US5889881A (en) | 1992-10-14 | 1996-05-10 | Method and apparatus for automatically detecting malignancy-associated changes |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/907,532 Continuation-In-Part US6026174A (en) | 1992-10-14 | 1997-08-08 | System and method for automatically detecting malignant cells and cells having malignancy-associated changes |
Publications (1)
Publication Number | Publication Date |
---|---|
US5942410A true US5942410A (en) | 1999-08-24 |
Family
ID=25393167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/888,434 Expired - Lifetime US5942410A (en) | 1992-10-14 | 1997-07-07 | Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol |
Country Status (6)
Country | Link |
---|---|
US (1) | US5942410A (en) |
EP (1) | EP0996852A1 (en) |
JP (1) | JP4212232B2 (en) |
AU (1) | AU8202998A (en) |
CA (1) | CA2295545C (en) |
WO (1) | WO1999002960A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6348325B1 (en) | 1999-10-29 | 2002-02-19 | Cytyc Corporation | Cytological stain composition |
US6527979B2 (en) * | 1999-08-27 | 2003-03-04 | Corazon Technologies, Inc. | Catheter systems and methods for their use in the treatment of calcified vascular occlusions |
US6593102B2 (en) | 1999-10-29 | 2003-07-15 | Cytyc Corporation | Cytological stain composition |
US20040042646A1 (en) * | 2002-08-29 | 2004-03-04 | Macaulay Calum E. | Computerized methods and systems related to the detection of malignancy-associated changes (MAC) to detect cancer |
US20040092026A1 (en) * | 2002-11-13 | 2004-05-13 | Ferguson Gary William | Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents |
US20050059955A1 (en) * | 1999-10-22 | 2005-03-17 | Dave Delaney | Catheter devices and methods for their use in the treatment of calcified vascular occlusions |
US20050202524A1 (en) * | 2004-03-15 | 2005-09-15 | Brusilovskiy Arkadiy I. | Tissue staining protocol and composition |
US20060161099A1 (en) * | 1998-07-15 | 2006-07-20 | Constantz Brent R | Methods and devices for reducing the mineral content of vascular calcified lesions |
US20060199243A1 (en) * | 2005-03-03 | 2006-09-07 | Garner David M | Cytological stain composition and methods of use |
US20070173784A1 (en) * | 1999-10-22 | 2007-07-26 | Peter Johansson | Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same |
CN111879592A (en) * | 2020-08-25 | 2020-11-03 | 湖南品胜生物技术有限公司 | Anti-falling cell DNA quantitative staining solution and preparation method thereof |
CN111999144A (en) * | 2020-08-25 | 2020-11-27 | 湖南品胜生物技术有限公司 | Anti-falling cell DNA quantitative staining method |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU754722B2 (en) | 1998-05-09 | 2002-11-21 | Ikonisys Inc. | Method and apparatus for computer controlled rare cell, including fetal cell, based diagnosis |
US7901887B2 (en) | 1998-05-09 | 2011-03-08 | Ikonisys, Inc. | Automated cancer diagnostic methods using fish |
WO2001037192A1 (en) | 1999-11-18 | 2001-05-25 | Ikonisys, Inc. | Method and apparatus for computer controlled cell based diagnosis |
TR200102815T1 (en) * | 2000-01-31 | 2002-05-21 | Zila, Inc. | In vivo staining compounds and methods to be used for the detection of tissue with dysplasia. |
CN102967499A (en) * | 2012-12-13 | 2013-03-13 | 麦克奥迪(厦门)医疗诊断系统有限公司 | Cell nucleus DNA (Deoxyribose Nucleic Acid) staining method |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0314293A2 (en) * | 1987-09-21 | 1989-05-03 | Cell Analysis Systems, Inc. | A kit and method for analyses of biological specimens |
US4998284A (en) * | 1987-11-17 | 1991-03-05 | Cell Analysis Systems, Inc. | Dual color camera microscope and methodology for cell staining and analysis |
US5016283A (en) * | 1985-11-04 | 1991-05-14 | Cell Analysis Systems, Inc. | Methods and apparatus for immunoploidy analysis |
EP0445434A2 (en) * | 1990-03-07 | 1991-09-11 | Cytyc Corporation | Thionin stain technique |
US5281517A (en) * | 1985-11-04 | 1994-01-25 | Cell Analysis Systems, Inc. | Methods for immunoploidy analysis |
US5432056A (en) * | 1993-11-15 | 1995-07-11 | Ventana Medical Systems, Inc. | Bisulfite-based tissue fixative |
US5485527A (en) * | 1985-11-04 | 1996-01-16 | Becton Dickinson And Company | Apparatus and method for analyses of biological specimens |
-
1997
- 1997-07-07 US US08/888,434 patent/US5942410A/en not_active Expired - Lifetime
-
1998
- 1998-07-07 EP EP98931863A patent/EP0996852A1/en not_active Withdrawn
- 1998-07-07 JP JP2000502393A patent/JP4212232B2/en not_active Expired - Fee Related
- 1998-07-07 AU AU82029/98A patent/AU8202998A/en not_active Abandoned
- 1998-07-07 CA CA002295545A patent/CA2295545C/en not_active Expired - Lifetime
- 1998-07-07 WO PCT/CA1998/000658 patent/WO1999002960A1/en not_active Application Discontinuation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5016283A (en) * | 1985-11-04 | 1991-05-14 | Cell Analysis Systems, Inc. | Methods and apparatus for immunoploidy analysis |
US5109429A (en) * | 1985-11-04 | 1992-04-28 | Cell Analysis Systems,Inc. | Apparatus and method for analyses of biological specimens |
US5281517A (en) * | 1985-11-04 | 1994-01-25 | Cell Analysis Systems, Inc. | Methods for immunoploidy analysis |
US5485527A (en) * | 1985-11-04 | 1996-01-16 | Becton Dickinson And Company | Apparatus and method for analyses of biological specimens |
EP0314293A2 (en) * | 1987-09-21 | 1989-05-03 | Cell Analysis Systems, Inc. | A kit and method for analyses of biological specimens |
US4998284A (en) * | 1987-11-17 | 1991-03-05 | Cell Analysis Systems, Inc. | Dual color camera microscope and methodology for cell staining and analysis |
EP0445434A2 (en) * | 1990-03-07 | 1991-09-11 | Cytyc Corporation | Thionin stain technique |
US5432056A (en) * | 1993-11-15 | 1995-07-11 | Ventana Medical Systems, Inc. | Bisulfite-based tissue fixative |
Non-Patent Citations (49)
Title |
---|
Bulstra, S.K. et al., "Thionin Staining of Paraffin and Plastic Embedded Sections of Cartilage," Biotechnic & Histochemistry, vol. 68, No. 1, 1993, pp. 20-28. |
Bulstra, S.K. et al., Thionin Staining of Paraffin and Plastic Embedded Sections of Cartilage, Biotechnic & Histochemistry, vol. 68, No. 1, 1993, pp. 20 28. * |
Cooper, J.D., et al., "Accurate Counting of Neurons in Frozen Sections: Some Necessary Precautions," J. Anatomy,vol. 157, 1988, pp. 13-21. |
Cooper, J.D., et al., Accurate Counting of Neurons in Frozen Sections: Some Necessary Precautions, J. Anatomy, vol. 157, 1988, pp. 13 21. * |
Doudkine, A, et al., "Nuclear Texture Measurements in Image Cytometry," Pathologica, vol. 87, 1995, pp. 286-299. |
Doudkine, A, et al., Nuclear Texture Measurements in Image Cytometry, Pathologica, vol. 87, 1995, pp. 286 299. * |
Dutt, M.K., "Use of Tris-Buffer-Fortified Thionine-SO2 for Detection of DNA-Aldehyde Following Feulgen Procedure," Microscopica Acta, vol. 83, No. 4, Sep. 1980, pp. 311-316. |
Dutt, M.K., Use of Tris Buffer Fortified Thionine SO 2 for Detection of DNA Aldehyde Following Feulgen Procedure, Microscopica Acta , vol. 83, No. 4, Sep. 1980, pp. 311 316. * |
Dutta et al., "Efect of organic solvents on dye-DNA interaction", Indian Journal of Chemistry, Nov. 1986. vol. 25A, pp. 1001-1003. |
Dutta et al., Efect of organic solvents on dye DNA interaction , Indian Journal of Chemistry, Nov. 1986. vol. 25A, pp. 1001 1003. * |
Feulgen, R., et al., Z. Physiol. Chem. vol. 136, 1924, pp. 57 61. * |
Feulgen, R., et al., Z. Physiol. Chem. vol. 136, 1924, pp. 57-61. |
Garner, D.M., et al., CytoSavant and Its Use in Automated Screening of Cervical Smears, in Compendium on The Computerized Cytology and Histology Laboratory, Wied, G.L., et al., eds., Tutorials of Cytology, Chicago, 1994. * |
Humason, Gretchen L., Animal Tissue Techniques, 4th Ed., W.H. Freeman & Company, San Francisco, 1979, pp. 154 155, 181 183, 208, 316 319, 432 433, 471 473. * |
Humason, Gretchen L., Animal Tissue Techniques, 4th Ed., W.H. Freeman & Company, San Francisco, 1979, pp. 154-155, 181-183, 208, 316-319, 432-433, 471-473. |
Insausti, R., et al., "The Human Entorhinal Cortex: A Cytoarchitectonic Analysis," The Journal of Comparative Neurology, vol. 355, 1995, pp. 171-198. |
Insausti, R., et al., The Human Entorhinal Cortex: A Cytoarchitectonic Analysis, The Journal of Comparative Neurology, vol. 355, 1995, pp. 171 198. * |
Jaggi, B., et al., "Design of a Solid-State Microscope, "Optical Engineering, Jun. 1989, vol. 28 No. 6, pp. 675-682. |
Jaggi, B., et al., "The Design and Development of an Optical Scanner for Cell Biology," IEEE Proceedings Engineering in Medicine and Biology Society, vol. 2, sep. 1985; pp. 980-985. |
Jaggi, B., et al., Design of a Solid State Microscope, Optical Engineering, Jun. 1989, vol. 28 No. 6, pp. 675 682. * |
Jaggi, B., et al., The Design and Development of an Optical Scanner for Cell Biology, IEEE Proceedings Engineering in Medicine and Biology Society, vol. 2, sep. 1985; pp. 980 985. * |
Kutscher, Charles L., et al., "Hematoxylin and Thionin Techniques for Staining Myeline and Cells: Variations and Critical Steps," Brain Research Bulletin, vol. 19, 1987, pp. 161-163. |
Kutscher, Charles L., et al., Hematoxylin and Thionin Techniques for Staining Myeline and Cells: Variations and Critical Steps, Brain Research Bulletin, vol. 19, 1987, pp. 161 163. * |
Mikel, Ulrika V., et al., "A Comparative Study of Quantitative Stains for DNA in Image Cytometry," Analytical and Quantitative Cytology and Histology, vol. 13, No. 4, Aug. 1991, pp. 253-260. |
Mikel, Ulrika V., et al., A Comparative Study of Quantitative Stains for DNA in Image Cytometry, Analytical and Quantitative Cytology and Histology, vol. 13, No. 4, Aug. 1991, pp. 253 260. * |
Muto, Tetsuichiro, et al., "Mucin Abnormality in Colonic Mucosa in Patients with Familial Polyposis Coli," Seminars in Surgical Oncology, vol. 3, 1987, pp. 179-182. |
Muto, Tetsuichiro, et al., Mucin Abnormality in Colonic Mucosa in Patients with Familial Polyposis Coli, Seminars in Surgical Oncology, vol. 3, 1987, pp. 179 182. * |
Ota, H., et al., "A Dual Staining Method for Identifying Mucins of Different Gastric Epithelial Mucous Cells," Histochemical Journal, vol. 23, 1991, pp. 22-28. |
Ota, H., et al., A Dual Staining Method for Identifying Mucins of Different Gastric Epithelial Mucous Cells, Histochemical Journal, vol. 23, 1991, pp. 22 28. * |
Poon, S.S.S., et al., "Cell Recognition Algorithms for the Cell Analyzer," IEEE Proceedings Engineering in Medicine and Biology Society, vol. 4, Nov. 1987; pp. 1454-1456. |
Poon, S.S.S., et al., Cell Recognition Algorithms for the Cell Analyzer, IEEE Proceedings Engineering in Medicine and Biology Society, vol. 4, Nov. 1987; pp. 1454 1456. * |
Schulte, E., et al., "The Influence of Cationic Thiazine Dyes on Eosin Y-Uptake of Red Blood Cells in Romanowsky-Giemsa Type," Acta Histochemica, Suppl.-Band XXXVII, S., 1989, pp. 139-147. |
Schulte, E., et al., The Influence of Cationic Thiazine Dyes on Eosin Y Uptake of Red Blood Cells in Romanowsky Giemsa Type, Acta Histochemica, Suppl. Band XXXVII, S., 1989, pp. 139 147. * |
Schulte, Erik, M.D., "Air Drying as a Preparatory Factor in Cytology: Investigation of its Influence on Dye Uptake and Dye Binding," Diagnostic Cytopatholgy, vol. 2, No. 2, Apri.-Jun. 1986, pp. 160-167. |
Schulte, Erik, M.D., Air Drying as a Preparatory Factor in Cytology: Investigation of its Influence on Dye Uptake and Dye Binding, Diagnostic Cytopatholgy, vol. 2, No. 2, Apri. Jun. 1986, pp. 160 167. * |
Schulte, Erik, M.D., et al., "Standardization of the Papanicolaou Stain: I. A Comparison of Five Nuclear Stains," Analytical and Quantitative Cytology and Histology, vol. No. 3, Jun. 1990, pp. 149-156. |
Schulte, Erik, M.D., et al., Standardization of the Papanicolaou Stain: I. A Comparison of Five Nuclear Stains, Analytical and Quantitative Cytology and Histology, vol. No. 3, Jun. 1990, pp. 149 156. * |
St o rmer, V.U., et al., Staining Properties and Applicability of Spectrally Pure Thionine and its Isomeres, Acta histochem., vol. 70, 1982, pp. 161 172. * |
Stormer, V.U., et al., "Staining Properties and Applicability of Spectrally Pure Thionine and its Isomeres," Acta histochem., vol. 70, 1982, pp. 161-172. |
Tolivia, J., et al., "Differential Technique to Stain Nerve Cells and Fibers in Methacrylate Sections," The Anatomical Record, vol. 217, 1987, pp. 318-320. |
Tolivia, J., et al., "Differential Thionin Block Staining of Nerve Cells and Fibers for Paraffin-Embedded Material in Mammalian Central Nervous System,"Neuroscience Letters, vol. 102, 1989, pp. 155-158. |
Tolivia, J., et al., Differential Technique to Stain Nerve Cells and Fibers in Methacrylate Sections, The Anatomical Record, vol. 217, 1987, pp. 318 320. * |
Tolivia, J., et al., Differential Thionin Block Staining of Nerve Cells and Fibers for Paraffin Embedded Material in Mammalian Central Nervous System, Neuroscience Letters, vol. 102, 1989, pp. 155 158. * |
Van Duijn, P., "A Histochemical Specific Thionine-SO2 Reagent and its Use in a Bi-Color Method for Deoxyribonucleic Acid and Periodic Acid Schiff Positive Substances," J. Histochem. Cytochem., vol 4, 1956, pp. 55-63. |
Van Duijn, P., A Histochemical Specific Thionine SO 2 Reagent and its Use in a Bi Color Method for Deoxyribonucleic Acid and Periodic Acid Schiff Positive Substances, J. Histochem. Cytochem., vol 4, 1956, pp. 55 63. * |
Winzek, C., et al., "An Improved Method to Investigate Staining Kinetics in Single Cells," Histochemistry, vol. 86, 1987, pp. 421-426. |
Winzek, C., et al., "Staining Kinetics in Single Cells: Part II. Diffusion Processes Inside the Cell," Histochemistry, vol. 90, 1988, pp. 79-83. |
Winzek, C., et al., An Improved Method to Investigate Staining Kinetics in Single Cells, Histochemistry, vol. 86, 1987, pp. 421 426. * |
Winzek, C., et al., Staining Kinetics in Single Cells: Part II. Diffusion Processes Inside the Cell, Histochemistry, vol. 90, 1988, pp. 79 83. * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060161099A1 (en) * | 1998-07-15 | 2006-07-20 | Constantz Brent R | Methods and devices for reducing the mineral content of vascular calcified lesions |
US6527979B2 (en) * | 1999-08-27 | 2003-03-04 | Corazon Technologies, Inc. | Catheter systems and methods for their use in the treatment of calcified vascular occlusions |
US8500683B2 (en) | 1999-08-27 | 2013-08-06 | Cordis Corporation | Catheter systems and methods for their use in the treatment of calcified vascular occlusions |
US20050059955A1 (en) * | 1999-10-22 | 2005-03-17 | Dave Delaney | Catheter devices and methods for their use in the treatment of calcified vascular occlusions |
US20070173784A1 (en) * | 1999-10-22 | 2007-07-26 | Peter Johansson | Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same |
US6348325B1 (en) | 1999-10-29 | 2002-02-19 | Cytyc Corporation | Cytological stain composition |
US6593102B2 (en) | 1999-10-29 | 2003-07-15 | Cytyc Corporation | Cytological stain composition |
US20040042646A1 (en) * | 2002-08-29 | 2004-03-04 | Macaulay Calum E. | Computerized methods and systems related to the detection of malignancy-associated changes (MAC) to detect cancer |
US7274809B2 (en) | 2002-08-29 | 2007-09-25 | Perceptronix Medical, Inc. And British Columbia Cancer Agency | Computerized methods and systems related to the detection of malignancy-associated changes (MAC) to detect cancer |
US7153691B2 (en) | 2002-11-13 | 2006-12-26 | G6 Science Corp. | Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents |
US20040092026A1 (en) * | 2002-11-13 | 2004-05-13 | Ferguson Gary William | Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents |
US20050202524A1 (en) * | 2004-03-15 | 2005-09-15 | Brusilovskiy Arkadiy I. | Tissue staining protocol and composition |
US20060199243A1 (en) * | 2005-03-03 | 2006-09-07 | Garner David M | Cytological stain composition and methods of use |
CN111879592A (en) * | 2020-08-25 | 2020-11-03 | 湖南品胜生物技术有限公司 | Anti-falling cell DNA quantitative staining solution and preparation method thereof |
CN111999144A (en) * | 2020-08-25 | 2020-11-27 | 湖南品胜生物技术有限公司 | Anti-falling cell DNA quantitative staining method |
Also Published As
Publication number | Publication date |
---|---|
JP2001509591A (en) | 2001-07-24 |
AU8202998A (en) | 1999-02-08 |
EP0996852A1 (en) | 2000-05-03 |
JP4212232B2 (en) | 2009-01-21 |
CA2295545C (en) | 2010-02-02 |
WO1999002960A8 (en) | 1999-08-05 |
WO1999002960A1 (en) | 1999-01-21 |
CA2295545A1 (en) | 1999-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5942410A (en) | Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol | |
Chieco et al. | The Feulgen reaction 75 years on | |
US5109429A (en) | Apparatus and method for analyses of biological specimens | |
US5485527A (en) | Apparatus and method for analyses of biological specimens | |
AU766614B2 (en) | Removal of embedding media from biological samples and cell conditioning on automated staining instruments | |
US4857300A (en) | Cytological and histological fixative formulation and methods for using same | |
US20060041385A1 (en) | Method of quantitating proteins and genes in cells using a combination of immunohistochemistry and in situ hybridization | |
EP2392909B1 (en) | Methods for a microemulsion-based tissue treatment | |
US20030175852A1 (en) | Ehancement of in situ hybridization | |
Biel et al. | From tissue to cellular ultrastructure: closing the gap between micro‐and nanostructural imaging | |
US5804448A (en) | Method of staining cellular material and analyzing the same | |
JP2005509140A (en) | A robust method for detecting and quantifying stains in histological specimens based on a physical model of stain absorption | |
EP0248840A1 (en) | An apparatus and method for analyses of biological specimens. | |
JP2012034699A (en) | Universal collection medium | |
Stöhr et al. | The Heidelberg flow analyzer and sorter (HEIFAS) approach on the prescreening of uterine cancer. | |
US20060199243A1 (en) | Cytological stain composition and methods of use | |
Franklin et al. | A new technique for retarding fading of fluorescence: DPX-BME | |
Woodruff et al. | Advantages of glycol methacrylate embedding systems for light microscopy | |
Van der Ploeg et al. | Dual wavelength scanning cytophotometry (BICOSCAN) | |
CA2341421C (en) | Removal of embedding media from biological samples and cell conditioning on automated staining instruments | |
Bottiroli et al. | Propidium iodide and the thiol‐specific reagent dacm as a dye pair for fluorescence resonance energy transfer analysis: An application to mouse sperm chromatin | |
JP3553691B2 (en) | Reticulocyte measuring reagent and measuring method | |
Dykstra et al. | Staining methods for semithins and ultrathins | |
Willingham et al. | Morphologic methods in the study of endocytosis in cultured cells | |
Wadsworth et al. | Quantitative analysis of atherosclerotic lesion composition in mice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ONCOMETRICS IMAGING CORP., CANADA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LAM, PAUL PONG-SHING;PAYNE, PETER WILLIAM;GARNER, DAVID MICHAEL;AND OTHERS;REEL/FRAME:009492/0090 Effective date: 19970917 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
AS | Assignment |
Owner name: MONOGEN, INC., ILLINOIS Free format text: LICENSE AND SECURITY AGREEMENT;ASSIGNOR:ONCOMETRICS IMAGING CORP.;REEL/FRAME:013718/0264 Effective date: 20021223 |
|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
SULP | Surcharge for late payment | ||
AS | Assignment |
Owner name: MUSIKANTOW-GOMBRICH, SUZANNE, ILLINOIS Free format text: SECURITY INTEREST;ASSIGNOR:MOLECULAR DIAGNOSTICS, INC.;REEL/FRAME:014517/0567 Effective date: 20030925 |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: LTOS); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
AS | Assignment |
Owner name: MOLECULAR DIAGNOSTICS, INC., ILLINOIS Free format text: SECURITY INTEREST TERMINATION;ASSIGNOR:MUSIKANTOW-GOMBRICH, MS. SUZANNE;REEL/FRAME:015201/0247 Effective date: 20040412 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
AS | Assignment |
Owner name: BRITISH COLUMBIA CANCER AGENCY BRANCH, CANADA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CYTOCORE INC.;ACCUMED INTERNATIONAL, INC.;ONCOMETRICS IMAGING CORP.;REEL/FRAME:019704/0764 Effective date: 20070802 |
|
AS | Assignment |
Owner name: PERCEPTRONIX MEDICAL INC., CANADA Free format text: EXCLUSIVE LICENSE;ASSIGNOR:THE BRITISH COLUMBIA CANCER AGENCY BRANCH;REEL/FRAME:019899/0775 Effective date: 20070824 |
|
FPAY | Fee payment |
Year of fee payment: 12 |